Skip to main content

Life sciences/Cell biology/Cells/Stem cells/Embryoid bodies

Traces of the transition from fins to limbs linger in the human body, Shubin said, with implications for biomedical research.

AAAS CEO Alan I. Leshner hailed a U.S. judge’s ruling Wednesday that allows continued federal funding of embryonic stem cell research, saying it would allow “extremely promising” medical research to advance.

U.S. District Court Judge Royce Lamberth dismissed a lawsuit challenging federal funding of embryonic stem cell research, deferring to a ruling by the U.S. Court of Appeals that the research did not violate a federal law that bars the government from funding research that requires the destruction of embryos.

AAAS today expressed strong concerns that a legal ruling blocking federally funded human embryonic stem cell research will badly delay medical progress that could someday save lives and treat devastating injuries and illness.

The uncertainty created by the 23 August ruling of U.S. District Judge Royce C. Lamberth “is bound to be tremendously disruptive to researchers endeavoring to advance human embryonic stem cell research to improve human quality of life,” said Albert Teich, director of Science and Policy Programs at AAAS.